Skip to main content
Fig. 2 | Acta Neuropathologica Communications

Fig. 2

From: Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice

Fig. 2

Elevation of FT in AD brains accompanied by an increase in H-Ras farnesylation and ERK activation in brains with MCI as well as AD. A Immunoblot analysis of FT-β subunit and GGT-1β subunit in the prefrontal cortical tissue lysates from individuals with no cognitive impairment (NCI), mild cognitive impairment (MCI), or Alzheimer’s disease (AD). B, C Densitometry analysis of FT-β and GGT-1β immunoblots normalized by tubulin with the levels in the NCI group set as 100%. D, E Immunoblot analysis of total H-Ras and densitometric analysis of H-Ras normalized by β-actin. F, G Immunoblot analysis of H-Ras in the membrane (M) and cytosolic (C) fractions. Immunoblot analysis of ER membrane-associated calnexin and cytosolic GAPDH confirms the separation of membrane-associated and cytosolic proteins. Ratios of membrane-associated (farnesylated) H-Ras to cytosolic (unfarnesylated) H-Ras were compared relative to the NCI group. H, I Immunoblot analysis of phospho-ERK (P-ERK) and total ERK in the brain tissue lysates. Ratios of P-ERK (activated) to total ERK were compared relative to the NCI group. J, K Positive correlations of membrane (farnesylated) H-Ras with FT and P-ERK levels by Pearson correlation analysis. n = 20 per group; B, C and E Kruskal–Wallis, 2-tailed with post-hoc Dunn’s multiple comparison test; G and I Wilcoxon signed rank-order test, 2-tailed; *p < 0.05; ***p < 0.005; ****p < 0.0001

Back to article page